Clinical and biochemical correlates of 'high-dose' clozapine therapy for treatment - Refractory schizophrenia [2]
- Peter F Buckley(corresponding author),
- A. C. Krowinski,
- D. D. Miller,
- L. Friedman,
- Y. Eaton,
- M. Tronetti
- ,
- Community Integration Inc.,
- University of Iowa,
- Case Western Reserve University
Scholary Output:
Contribution to journal
Letter
Peer-reviewSustainable Development Goals
SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 225-227 (3 pages)Journal (Volume, Issue Number)
Schizophrenia Research (Volume 49, Issue 1-2)Publication milestones
- Published - 04/15/2001
Publication status
Published - 04/15/2001
ISSN
0920-9964Publication IDs
- Scopus: 0035871091
- PubMed: 11428347
Publication metrics
Metrics
SciVal
FWCI
0.50
SciVal
Author count
6
SciVal
citations
13
SciVal
Paper percentile
63
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
10
Captures
12
Funding Details
This work was supported in part by a grant from Novartis Pharmaceuticals Corporation. The secretarial assistance of Ms Andrea J. Miles is greatly appreciated. We are also grateful to Craig Richman, MD, Penny Chapman, MD, John Evans, Lee Penman, and Michelle Donovic, through Cll, Erie, for their assistance and support of this project.
FunderFunding numbers
NPC
-